Company intelligence / Profile preview

Oncology Metrics

The Woodlands, Texas, United States

Ownership: Private
Development stage: Other

Overview

Oncology Metrics was a specialized healthcare data and consulting firm that provided financial and operational benchmarking data for community oncology practices. The company focused on collecting and analyzing practice-level data to help oncologists improve business performance and clinical quality. It was widely known for its annual 'Oncology Metrics Study,' which served as a primary resource for understanding the economic trends of independent oncology clinics. In 2010, the company was acquired by McKesson as part of its Specialty Health division to enhance its data analytics capabilities for the US Oncology Network.

Therapeutic areas: Oncology
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

The US Oncology Network

Beyond the preview

Go deeper on Oncology Metrics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oncology Metrics.

Explore the full profile